New international recommendations for type 2 diabetes - what are we doing in Norway?

被引：0
|
作者：
Birkeland, Kare, I [1 ,2 ]
Meling, Sondre [3 ,4 ]
Gullestad, Lars [1 ,5 ]
Alsnes, Ingvild Vatten [6 ]
Jenssen, Trond G. [1 ,2 ]
Svensson, Emelie
机构：
[1] Univ Oslo, Oslo, Norway
[2] Oslo Univ Sykehus, Rikshosp, Nyreseksjonen, Oslo, Norway
[3] Stavanger Univ Sjukehus, Endokrinol Seksjon, Stavanger, Norway
[4] Univ Bergen, Bergen, Norway
[5] Oslo Univ Sykehus, Hjertemedisinsk Avdeling, Rikshosp, Oslo, Norway
[6] Univ Stavanger, Stavanger, Norway
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2023年 / 143卷 / 03期
关键词：
MORTALITY; BLIND;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：218 / 220
页数：3
相关论文
共 50 条
  • [21] New Insights in the Prevention and Early Management of Type 2 Diabetes
    Lau, David C. W.
    CANADIAN JOURNAL OF DIABETES, 2011, 35 (03) : 239 - 241
  • [22] Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
    Abu-Alfa, Ali K.
    Atallah, Paola J.
    Azar, Sami T.
    Dagher, Elissar C.
    Echtay, Akram S.
    El-Amm, Mireille A.
    Hazkial, Habib G.
    Kassab, Roland Y.
    Medlej, Rita C.
    Mohamad, Malek A.
    DIABETES THERAPY, 2023, 14 (01) : 11 - 28
  • [23] Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: What makes the difference?
    Monami, M.
    Marchionni, N.
    Masotti, G.
    Mannucci, E.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (08) : 626 - 630
  • [24] Family history of diabetes predisposes to cardiovascular disease among patients with type 2 diabetes: What is the nature of the association?
    Bonnet, F.
    Balkau, B.
    Natali, A.
    DIABETES & METABOLISM, 2016, 42 (03) : 139 - 141
  • [25] Prognostic value of International Diabetes Federation and Adult Treatment Panel III definitions of metabolic syndrome in Type 2 diabetic patients: What makes the difference?
    M. Monami
    N. Marchionni
    G. Masotti
    E. Mannucci
    Journal of Endocrinological Investigation, 2007, 30 : 626 - 630
  • [26] The US Prevalence of Metabolic Surgery in Patients with Obesity and Type 2 Diabetes Has Not Increased Despite Recommendations from the American Diabetes Association
    Altieri, Maria S.
    Irish, William
    Pories, Walter J.
    DeMaria, Eric J.
    OBESITY SURGERY, 2022, 32 (04) : 1086 - 1092
  • [27] New insights into the older hypoglycemic agents in type 2 diabetes therapy
    Cao, Min
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2020, 12 (11) : 844 - 847
  • [28] Type 2 Diabetes: After Metformin - Are New Studies changing Therapy?
    Elbelt, Ulf
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (11) : 772 - 776
  • [29] Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes The New Zealand Diabetes Cohort Study
    Elley, C. Raina
    Robinson, Elizabeth
    Kenealy, Tim
    Bramley, Dale
    Drury, Paul L.
    DIABETES CARE, 2010, 33 (06) : 1347 - 1352
  • [30] Nonalcooholic steatohepatitis: Should we screen high-risk patients with type 2 diabetes or obesity?
    Caussy, Cyrielle
    NUTRITION CLINIQUE ET METABOLISME, 2020, 34 (02): : 122 - 129
12345